1.Effects of phenytoin on VEGF and SCF in rat bone marrow mesenchymal stem cells and vascular endothelial cells co-culture system
Shan HE ; Liyue ZHAO ; Xiaoye BA ; Baoyan WANG ; Jianling SONG
Journal of Xi'an Jiaotong University(Medical Sciences) 2016;(2):204-208,225
ABSTRACT:Objective To investigate the effects of phenytoin (PHT)on the secretion of vascular endothelial growth factor (VEGF)and stem cell factor (SCF)based on the establishment of indirect co-culture system of rat bone marrow mesenchymal stem cells (BMSCs)and vascular endothelial cells (VECs).Methods Indirect co-culture model of rat BMSCs and VECs was established.Experimental groups:indirect co-culture groups (PHT concentrations were 0,20 and 40 μg/mL);the control group:BMSCs culture group and VECs culture group (PHT concentrations were 0,20 and 40μg/mL).The contents of VEGF and SCF in the culture supernatant were measured using double antibody sandwich ABC-ELISA method on cultivation days 2,4,6.Results ELISA assay of the rBMSCs and rVECs in indirect co-culture supernatants,collected on culture days 2,4 and 6 showed that:① VEGF:On culture day 2,VEGF level in the co-culture groups was significantly higher than those in BMSCs group (P <0.05)and rVECs group (P <0.001).As culture time prolonged and PHT concentration increased to 20 μg/mL and 40 μg/mL,VEGF level increased too (P <0.001,P <0.05 ).② SCF testing results showed that the secretion of SCF in co-culture groups was higher than that in the control groups.When PHT was 20 μg/mL,the secretion of
SCF increased as the incubation time increased;but as the incubation time increased, PHT concentration of 40 μg/mL made SCF content decrease.Each group did not significantly differ (P > 0.05 ).Conclusion PHT promotes the secretion of VEGF and may reduce the secretion of SCF.
2.Protective Effects of Tilianin on Brain Tissue in Cerebral Ischemia-reperfusion Injury Model Rats
Liyue MA ; Cheng ZENG ; Ruifang ZHENG ; Wen JIANG ; Chenghui HE ; Jianguo XING
China Pharmacy 2018;29(20):2805-2810
OBJECTIVE:To study the effects of tilianin(TIL)on brain tissue in rats with cerebral ischemia-reperfusion injury. METHODS:Totally 120 male SD rats were randomly divided into sham operation group(0.9% sodium chloride solution),model group(0.9% sodium chloride solution),nimodipine group(32 mg/kg)and TIL low-dose and medium-dose,high-dose groups(4, 8,16 mg/kg),with 20 rats in each group. The rats were given relevant medicine intragastrically,once a day,for consecutive 7 d. 15 min after last medication,cerebral ischemia-reperfusion injury model was established by reforming suture-occluded method. The neurological deficit score in rats were evaluated, and percentage of cerebral infarction volume of rats was determined. Histopathological changes of brain tissue were observed by HE staining. The activities of SOD,CAT and LDH,MDA content in cerebral tissue of rats were determined. The expression of calcitonin gene-related peptide(CGRP)and peripheral vascular endothelial growth factor receptor 2 (VEGFR2) protein were determined by Western blot assay. RESULTS:Compared with sham operation group,neurological deficit score and percentage of cerebral infarction volume of model group were increased significantly(P<0.01);the nerve cells in brain tissue were significantly reduced and the interstitial edema was obvious. SOD and CAT activities were decreased significantly,LDH activity was increased significantly,MDA content was decreased significantly,protein expression of CGRP and VEGFR2were increased significantly(P<0.05 or P<0.01). Compared with model group,neurological deficit score of nimodipine group,TIL medium-dose and high-dose groups were decreased significantly;percentage of cerebral infarction volume was decreased significantly (P<0.05 or P<0.01);above pathological conditions of cerebral tissue in rats were relieved significantly;SOD and CAT activities were strengthened significantly,MDA content and LDH activities were decreased significantly,protein expression of CGRP and VEGFR2were increased significantly (P<0.05 or P<0.01). CONCLUSIONS: TIL has certain protective effects on cerebral ischemia-reperfusion injury model rats,and its mechanism may be related to the up-regulation of CGRP and VEGFR2expression.
3.Implantation Strategies of Invasive Flexible Neural Electrode
Yuxin HE ; Wenguang ZHANG ; Liyue XU ; Xuhui ZHOU
Journal of Medical Biomechanics 2021;36(1):E151-E157
Invasive neural electrodes promote human understanding of neuroscience to the micrometer and millisecond scale. Due to the large mechanical mismatch between traditional rigid electrodes and soft brain tissues, flexible electrodes have become the new trend of neural electrodes. The flexibility of the neural electrode reduces the immune response while losing the implantation stiffness. The implantation mechanism of the neural electrode was reviewed and current researches on the implantation strategies of the flexible electrodes were summarized, so as to help solve the loss of implantation ability of flexible electrode and acute implantation injury. Based on the characteristics of various implantation strategies, the prospect of flexible electrode implantation strategies was proposed.
4.Analysis of Direct Medical Expense of Patients with Pulmonary Embolism and Its Influential Factors in China :Based on 2014 National Urban Basic Medical Insurance Data
Junfeng WANG ; Li YANG ; Jingjing WU ; Liyue HE
China Pharmacy 2019;30(22):3122-3127
OBJECTIVE: To study direct medical expense and its influential factors, and to provide empirical reference for medical expenses control of pulmonary embolism and the adjustment of anticoagulant drug reimbursement strategy. METHODS: Based on the national urban basic medical insurance data in 2014, the data of patients with pulmonary embolism were extracted by equidistant sampling method to form a sample database. According to related therapy information and expense information of pulmonary embolism patients in sample database, descriptive analysis was performed for demographic characteristics of patients (including gender, age, type of medical insurance, region, type of medical institution, etc.), direct medical expenses and direct medical expenses of patients with different anticoagulants, etc. Multiple linear regression analysis was used to analyze potential influential factors for the medical expenses of patients. RESULTS: A total of 475 pulmonary embolism patients were included, a total of 1 090 visits were recorded, and the average length of stay was 12.37 days. The annual medical expense per capita of patients was 10 847.42 yuan (median was 4 113.00 yuan), hospitalization expense per capita was 19 056.30 yuan (median was 13 042.86 yuan), and outpatient expense per capita was 1 049.61 yuan (median was 418.70 yuan). Results of subgroup analysis showed that annual medical expense in eastern, central and western cities were 9 203.54, 16 931.99 and 15 891.21 yuan. Per capita annual medical expenses of patients in tertiary hospitals were the highest (11 733.40 yuan), followed by secondary hospitals, and the lowest was other medical related institutions. Among different anticoagulants treatment groups, the annual medical expense per capita (24 553.80 yuan) and annual drug expense per capita (12 088.96 yuan) were the highest in anticoagulant regimen of combined use of LMWH and UFH, while patients treated with warfarin alone had the lowest annual medical expense per capia (2 350.24 yuan) and annual drug expense per capita (1 163.67 yuan). The multiple linear regression showed that the factors affecting medical expense per visit were type of patient (inpatient or outpatient),type of medical institution and type of complications. CONCLUSIONS: Direct medical expense per capita of patients with pulmonary embolism is still high, and the economic burden of disease is still heavy. Patients with pulmonary embolism treated with combination of LMWH and UFH had the highest medical expense per capita. The types of visit, types of medical institutions and complications can influence medical expense of patients significantly.
5.Effect Evaluation of PBM Pilots in Wuhu City of Anhui Province from the Perspective of Patients
Liyue HE ; Junfeng WANG ; Xiaoyan WU ; Xinyi LIU ; Li YANG
China Pharmacy 2019;30(6):725-730
OBJECTIVE: To evaluate the effects of Pharmacy Benefit Management (PBM) model on drug compliance, health outcomes, economic burden and satisfaction of patients in Wuhu city of Anhui province. METHODS: In cross-sectional study, the questionnaires were designed according to the National Health Service Survey. Through cluster sampling and convenient sampling, the questionnaire survey (including subjective evaluation) was conducted among hypertensive patients who participated in or did not participate in the PBM program in pilot area of Wuhu city. Descriptive analysis was used to analyze the general characteristics of the two groups. The Propensity Score Matching (PSM) was used to approximately randomize the included data to balance the baseline characteristics. Univariate linear regression or Logistic regression analysis were used to evaluate the relationship of whether to join PBM or not with drug compliance,QALY, hospitalization probability,monthly average drug cost for chronic diseases and monthly self-paid drug cost for chronic diseases, etc. RESULTS: A total of 755 valid questionnaires were collected, including 405 in the PBM group and 350 in the non-participating group. There was statistical significance in patient’s gender, age, education degree, nature of household registration, type of medical insurance or usual visited medical institutions (P<0.05). About 95% patients (405 cases) satisfied with PBM program. 281 cases of PBM group and 193 cases of non-participating group were included through PSM. Results of regression analysis showed that lower one level at least of medication compliance in PBM group was 0.49 times as that in the non-participating group; the hospitalization probability in PBM group was 0.56 times as that in the non-participating group (P<0.05). There was no statistical significance of difference in control of blood pressure QALY, monthly average drug cost for chronic diseases and monthly self-paid drug cost for chronic diseases between two groups (P>0.05). CONCLUSIONS: The implementation of PBM model in pilot areas can improve drug compliance and reduce hospitalization rate of patients. The most patients are highly satisfied. However, the effects of PBM on patients’ control of blood pressure, QALY and medical expense are not obvious, and its long-term effect needs more follow-up studies to verify.
6.Construction of a whole business process supervision and management system: based on management information system of blood banks
Weidong HE ; Zhiquan RONG ; Chen XIAO ; Junlei HUANG ; Na HU ; Xuefeng LIANG ; Liyue JIANG ; Caina LI ; Wei WEI ; Yan LIU
Chinese Journal of Blood Transfusion 2024;37(4):455-461
【Objective】 To achieve supervision and management of the whole business process of blood center, raise productivity and ensure blood quality by enabling blood center managers comprehensively grasp the key business operation situation of the whole process at anytime and anywhere. 【Methods】 A whole business process supervision and management system was established covering background of preparation, business scope, content of position supervision and management, overall framework design, interface design of management and supervision management, physical database design, program development and online debugging, and was integrated with the blood bank management information system. The display and management were through a mobile APP to record key indicators of business process from blood collection to blood supply timely and comprehensively. Statistical analysis was conducted on total collection volume, total preparation volume and total supply volume, as well as discarding rate of test unqualified and of non-test unqualified (lipemic blood excluded) in 2023 and 2022. 【Results】 We established a mobile APP based on a blood bank management information system for business supervision and management of whole process, and achieved management by phones. After its implementation in 2023, the total collection volume, total preparation volume and total supply volume in 2023 were all higher than those in 2022, with growth rates of 5.88% (13 247/225 454 U), 4.73% (24 156/510 698 U), and 6.70% (34 814/519 914 U), respectively. The discarding rate in 2023 was lower than that in 2022 (0.54%, 2 868/534 854 U) vs (0.60%, 3 047/510 698 U) (P<0.01), and the non-test unqualified discarding rate (lipemic blood excluded) in 2023 was significantly lower than that in 2022(0.12%, 649/534 854 U) vs (0.19%, 991/510 698 U)(P<0.01). 【Conclusion】 The construction of supervision and management system of a whole business process based on blood bank management information system can meet the standardized service needs of managers at anytime and anywhere, continuously raise productivity and the standardization and scientific level of blood bank management, thus ensuring blood supply.